Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Aug 14, 2024

SELL
$0.72 - $1.28 $1,966 - $3,495
-2,731 Closed
0 $0
Q3 2022

Aug 14, 2024

SELL
$1.11 - $2.78 $2,432 - $6,090
-2,191 Reduced 44.51%
2,731 $3.41 Million
Q2 2022

Aug 14, 2024

SELL
$2.06 - $4.25 $4,944 - $10,200
-2,400 Reduced 32.78%
4,922 $12.2 Million
Q1 2022

Aug 14, 2024

BUY
$3.3 - $5.44 $24,162 - $39,831
7,322 New
7,322 $30.1 Million
Q2 2021

Aug 30, 2024

BUY
$9.02 - $12.93 $66,044 - $94,673
7,322 New
7,322 $76.4 Million

Others Institutions Holding CNTG

About Centogene N.V.


  • Ticker CNTG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 27,081,600
  • Market Cap $2.98M
  • Description
  • Centogene N.V., together with its subsidiaries, focuses on rare diseases that transforms real-world clinical and genetic, or other data into actionable information for patients, physicians, and pharmaceutical companies worldwide. It operates through three segments: Pharmaceutical, Diagnostics, and COVID-19 testing. The company develops rare dise...
More about CNTG
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.